Europe Bifurcation Lesions Market Size & Outlook

The bifurcation lesions market in Europe is expected to reach a projected revenue of US$ 1,022.0 million by 2030. A compound annual growth rate of 6.2% is expected of Europe bifurcation lesions market from 2024 to 2030.
Revenue, 2023 (US$M)
$672.5
Forecast, 2030 (US$M)
$1,022.0
CAGR, 2024 - 2030
6.2%
Report Coverage
Europe

Europe bifurcation lesions market, 2018-2030 (US$M)

Europe

Europe bifurcation lesions market highlights

  • The Europe bifurcation lesions market generated a revenue of USD 672.5 million in 2023.
  • The market is expected to grow at a CAGR of 6.2% from 2024 to 2030.
  • In terms of segment, peripheral was the largest revenue generating application in 2023.
  • Peripheral is the most lucrative application segment registering the fastest growth during the forecast period.


Europe data book summary

Market revenue in 2023USD 672.5 million
Market revenue in 2030USD 1,022.0 million
Growth rate6.2% (CAGR from 2023 to 2030)
Largest segmentPeripheral
Fastest growing segmentPeripheral
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPeripheral
Key market players worldwideBoston Scientific Corp, Abbott Laboratories, Cardinal Health Inc, Medtronic PLC, BD, Johnson & Johnson, Koninklijke Philips NV, Terumo Corp, Tenon Medical Inc


Other key industry trends

  • In terms of revenue, Europe region accounted for 28.9% of the global bifurcation lesions market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 976.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Bifurcation Lesions Market Scope

Bifurcation lesions market segmentation & scope
Peripheral
Coronary
Countries
Argentina
Mexico
Brazil
UK
Germany
France
Italy
Spain
Sweden
Norway
Denmark
U.S.
Canada
UAE
South Africa
Saudi Arabia
Kuwait
India
China
Japan
South Korea
Thailand
Australia

Bifurcation Lesions Market Companies

Name Profile # Employees HQ Website

Europe bifurcation lesions market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bifurcation lesions market will help companies and investors design strategic landscapes.


Peripheral was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Europe bifurcation lesions market based on peripheral covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Europe bifurcation lesions market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe bifurcation lesions market databook

  • Our clientele includes a mix of bifurcation lesions market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe bifurcation lesions market , including forecasts for subscribers. This continent databook contains high-level insights into Europe bifurcation lesions market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe bifurcation lesions market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more